Compile Data Set for Download or QSAR
Report error Found 4679 of ic50 data for polymerid = 470
LigandPNGBDBM305704(US10144734, Example 722 | 2-chloro-N-((3S,4S)-1-(5...)
Affinity DataIC50: 2nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305704(US10144734, Example 722 | 2-chloro-N-((3S,4S)-1-(5...)
Affinity DataIC50: 2nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305705(US10144734, Example 723 | 2-chloro-N-((3S,4S)-1-(5...)
Affinity DataIC50: 3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305757(US10144734, Example 775 | 3-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305759(US10144734, Example 777 | 3-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305765(US10144734, Example 783 | 2-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305705(US10144734, Example 723 | 2-chloro-N-((3S,4S)-1-(5...)
Affinity DataIC50: 3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305757(US10144734, Example 775 | 3-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305765(US10144734, Example 783 | 2-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305759(US10144734, Example 777 | 3-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 3nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305468(US10144734, Example 485 | US10172845, Example 485 ...)
Affinity DataIC50: 3.70nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305672(US10144734, Example 690 | US10172845, Example 690 ...)
Affinity DataIC50: 3.70nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305672(US10144734, Example 690 | US10172845, Example 690 ...)
Affinity DataIC50: 3.70nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305468(US10144734, Example 485 | US10172845, Example 485 ...)
Affinity DataIC50: 3.70nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305707(US10144734, Example 725 | N-((3S,4S)-1-(5-(3-cyano...)
Affinity DataIC50: 4nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305724(US10144734, Example 742 | 4-(6-(4-(3-fluorobenzyl)...)
Affinity DataIC50: 4nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305752(US10144734, Example 770 | US10172845, Example 770 ...)
Affinity DataIC50: 4nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305752(US10144734, Example 770 | US10172845, Example 770 ...)
Affinity DataIC50: 4nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305724(US10144734, Example 742 | 4-(6-(4-(3-fluorobenzyl)...)
Affinity DataIC50: 4nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305707(US10144734, Example 725 | N-((3S,4S)-1-(5-(3-cyano...)
Affinity DataIC50: 4nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305355(US10144734, Example 371 | US10172845, Example 371 ...)
Affinity DataIC50: 4.20nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305355(US10144734, Example 371 | US10172845, Example 371 ...)
Affinity DataIC50: 4.20nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305346(US11648243, Example 362 | US10144734, Example 362 ...)
Affinity DataIC50: 4.40nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305346(US11648243, Example 362 | US10144734, Example 362 ...)
Affinity DataIC50: 4.40nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305687(US10144734, Example 705 | US10172845, Example 705 ...)
Affinity DataIC50: 4.60nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305687(US10144734, Example 705 | US10172845, Example 705 ...)
Affinity DataIC50: 4.60nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305712(US10144734, Example 730 | N-((3S,4S)-3-amino-1-(5-...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305713(US10144734, Example 731 | N-((3S,4S)-3-amino-1-(5-...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305776(US10144734, Example 794 | 2-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305778(US10144734, Example 796 | 3-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305789(US10144734, Example 807 | US10172845, Example 807 ...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305171(4-(6-(3-(3,5- difluorophenoxy)azetidin- 1-yl)pyrid...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305670(US10144734, Example 688 | US10172845, Example 688 ...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305171(4-(6-(3-(3,5- difluorophenoxy)azetidin- 1-yl)pyrid...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305789(US10144734, Example 807 | US10172845, Example 807 ...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305776(US10144734, Example 794 | 2-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305713(US10144734, Example 731 | N-((3S,4S)-3-amino-1-(5-...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305778(US10144734, Example 796 | 3-chloro-N-(1-(5-(3- cya...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305670(US10144734, Example 688 | US10172845, Example 688 ...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305712(US10144734, Example 730 | N-((3S,4S)-3-amino-1-(5-...)
Affinity DataIC50: 5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305662(US10144734, Example 680 | US10172845, Example 680 ...)
Affinity DataIC50: 5.20nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305662(US10144734, Example 680 | US10172845, Example 680 ...)
Affinity DataIC50: 5.20nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305071(US10144734, Example 87 | US10172845, Example 87 | ...)
Affinity DataIC50: 5.30nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305071(US10144734, Example 87 | US10172845, Example 87 | ...)
Affinity DataIC50: 5.30nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM315710(US10172845, Example 363 | US10441581, Example 363 ...)
Affinity DataIC50: 5.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305470(US10144734, Example 487 | US10172845, Example 487 ...)
Affinity DataIC50: 5.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM315710(US10172845, Example 363 | US10441581, Example 363 ...)
Affinity DataIC50: 5.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305470(US10144734, Example 487 | US10172845, Example 487 ...)
Affinity DataIC50: 5.5nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK assay tech...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM284476(US10023570, Example 489 | US10174027, Example 489)
Affinity DataIC50: 5.70nMpH: 7.4Assay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF KinEASE -TK a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM305367(US10144734, Example 384 | US10172845, Example 384 ...)
Affinity DataIC50: 5.70nMAssay Description:Compounds of Formula I were screened for their ability to inhibit wildtype and V804M mutant RET kinase using CisBio's HTRF KinEASE-TK assay techn...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 4679 total ) | Next | Last >>
Jump to: